Home LiteratureArticle Details
PMID: 1731340 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

Kruys V, Kemmer K, Shakhov A, Jongeneel V, Beutler B

Abstract

The role of the mouse tumor necrosis factor (TNF) promoter, 5' untranslated region (UTR), and 3' UTR in TNF gene expression has been examined in three nonmacrophage cell lines (HeLa, NIH 3T3, and L-929). The TNF promoter is not macrophage-specific. On the contrary, it constitutively drives reporter gene expression in all three cell lines. Not only the full-length promoter but also truncated versions of the promoter, lacking NF-kappa B binding motifs, are active in each type of cell. The TNF 3' UTR effectively cancels reporter gene expression in HeLa cells and in NIH 3T3 cells but fails to block expression in L-929 cells. L-929 cells contain a factor that overcomes the inhibitory influence of the TNF 3' UTR. Its action depends upon the presence of sequences found in the TNF 5' UTR. Cell-fusion experiments reveal that this activator is trans-dominant. These studies highlight the essential role played by the TNF 3' UTR, which silences the TNF gene in cells that might otherwise express TNF. They also reveal the existence of an escape mechanism whereby inappropriate synthesis of TNF might occur.

MeSH Terms
3T3 Cells Animals Cell Fusion Gene Expression Regulation HeLa Cells Humans L Cells Mice Promoter Regions, Genetic RNA, Messenger/genetics Trans-Activators Transcription, Genetic Tumor Necrosis Factor-alpha/genetics
Chemicals
RNA, Messenger Trans-Activators Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kruys V
Howard Hughes Medical Institute, Dallas, TX 75235-9050.
Kemmer K
Shakhov A
Jongeneel V
Beutler B
References (17)
17 references, click to expand
  1. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
    J Exp Med. 1987 Jun 1;165(6):1581-94 PMID: 3108447
  2. A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.
    J Clin Invest. 1991 Apr;87(4):1336-44 PMID: 2010547
  3. Molecular control of tissue-specific expression at the mouse TNF locus.
    Eur J Immunol. 1989 Mar;19(3):549-52 PMID: 2785049
  4. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.
    J Exp Med. 1988 Nov 1;168(5):1539-51 PMID: 3263462
  5. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.
    Proc Natl Acad Sci U S A. 1987 Sep;84(18):6563-6 PMID: 3476961
  6. Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas.
    J Immunol. 1990 May 1;144(9):3424-30 PMID: 2329277
  7. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level.
    J Exp Med. 1990 Feb 1;171(2):465-75 PMID: 2303781
  8. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages.
    J Exp Med. 1990 Jan 1;171(1):35-47 PMID: 2104921
  9. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
    Mol Cell Biol. 1982 Sep;2(9):1044-51 PMID: 6960240
  10. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
    Cell. 1986 Aug 29;46(5):659-67 PMID: 3488815
  11. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  12. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.
    Nucleic Acids Res. 1987 Jul 10;15(13):5490 PMID: 3037497
  13. High-efficiency transformation of mammalian cells by plasmid DNA.
    Mol Cell Biol. 1987 Aug;7(8):2745-52 PMID: 3670292
  14. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
    J Exp Med. 1986 Oct 1;164(4):1350-5 PMID: 3020152
  15. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    J Exp Med. 1985 Nov 1;162(5):1512-30 PMID: 3932579
  16. Tumor necrosis factor expression in human epithelial tumor cell lines.
    J Clin Invest. 1988 Feb;81(2):455-60 PMID: 2828427
  17. Translational blockade imposed by cytokine-derived UA-rich sequences.
    Science. 1989 Aug 25;245(4920):852-5 PMID: 2672333
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1992-01-15
Pages
673-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC48301
Subset
IM
Grants
NCI NIH HHS · 5RO1-CA45525 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]